3/8/2021ACG: Some Health Insurance Practices Undermine Consumers' Perception o...

3/8/2021Winhealth and Merz Collaborate Enter Distribution Pact for Liver Dise...

3/8/2021CStone Forges Strategic Alliance with Sinopharm for Commercialization ...

3/8/2021Eli Lilly Launches Verzenio (Abemaciclib) in China

3/8/2021FT: Pharma Groups Spend Billions to Tap into Booming China Healthcare

3/5/2021Junshi Initiates Toripalimab Rolling BLA Submission for Nasopharyngeal...

3/5/2021Premier Delivers Government Work Report at the NPC Session (with Summa...

3/5/2021Recent Executive Moves

3/5/2021Spring Promotion - Pharma China publications

3/4/2021SciClone Launches IPO on the Main Board of the Hong Kong Stock Exchang...

3/4/2021NMPA Issues the List of Reference Formulations for GQCE Studies (39th ...

3/4/2021GSK Granted Approval for 2nd Indication of Lamictal Dispersible Tablet...

3/4/2021NHC: China Achieves Phased Success with Its Tiered Medical System Buil...

3/4/2021NHC Holds National Drug Administration Teleconference, Highlighting Di...

3/4/2021China To Set Up 20 More IPR Centers In 2021

3/4/2021DSM Wins Patent Case against China’s Anhui Tiger Vitamin

3/4/2021Amgen Buys Five Prime to Expand in Asia-Pacific’s Oncology Market

3/4/2021Abcam Expands in China to Meet Increased Demand of BioPharma Sector

3/4/2021China's Supreme People's Court Issues Law Interpretation for Intellect...

3/4/2021Antitrust in China – 2020 Year in Review

3/3/2021 Innoforce and dMed Collaborate to Accelerate the Development of Innov...

3/3/2021Merck and Guangzhou Pharma Sign MOU for Alliance in GD-HK-Macao Greate...

3/3/2021FBI Accuses Former Jackson Lab Researcher of Failing to Disclose China...

3/3/2021NMPA Revises Packages Inserts of Tramadol Injection and Single-ingredi...

3/3/2021Sun Pharma's NDA for Odomzo (Sonidegib) to be Granted Priority Review

3/3/2021ADC Developer Suzhou Medilink Therapeutics Secures $50M in A1 Financin...

3/3/2021Starton Secures Licensing Deal with Haisco to Develop Post-cancer Naus...

3/2/2021ADC Developer Suzhou Medilink Therapeutics Secures $50M in A1 Financin...

3/2/2021NMPA Withdraws Approvals of 226 Drug Products Including 12 MNC Product...

3/2/2021WuXi AppTec Completes Acquisition of Gene Therapy CRDO OXGENE

Page:141/719 Total number of articles:21555: [First][<<] [139] [140] [141] [142] [143] [>>] [End]